
Peptide Synthesis & Customized Peptide Synthesis for Life ... - GenScript
GenScript offers reliable custom peptide synthesis using state-of-the-art microwave technology for epitope mapping and drug discovery applications.
GenScript Expands Peptide Production Capabilities to Include …
Aug 8, 2023 · It leverages GenScript's extensive manufacturing expertise in the synthesis of complex and modified peptides, including cyclic peptides, peptide-drug conjugates (PDCs), …
GenScript’s high-throughput parallel peptide synthesis platform and 10,000 peptide/month synthesis capacity facilitate a range of cost-effective peptide library services to meet your …
Custom Peptide Synthesis and Library Services - GenScript
GenScript offers comprehensive peptide services, including custom peptide synthesis and high-throughput peptide libraries, with both research and cGMP-grade options. Leveraging the …
Peppower™ Peptide Synthesis Platform | GenScript
As a pioneer in the life science research service industry, GenScript developed PepPower™, the advanced peptide synthesis platform, to synthesize high quality Custom peptide, Express …
Large Scale Peptide Synthesis Service - GenScript
With over 17 years of experience and newly large-scale peptide synthesis platform, our chemists will work to create a smooth, professional scale-up experience from protocol design to product …
GenScript - Scripting Possibilities - The leader in molecular …
Sep 17, 2025 · As a leading biotech company focusing exclusively on early drug discovery and development services, GenScript provides a comprehensive portfolio of services that include …
cGMP Peptide Synthesis - GenScript
GenScript offers the manufacturing expertise, capacity, and validated platform processes to accelerate your neoantigen and API peptide from early drug discovery to the clinic Phase I/II …
PepHTS™ Peptide Library Synthesis Platform | GenScript
Empowered by this PepHTS™ Library Platform, GenScript can secure accurately controlled peptide synthesis with full automation, which also significantly increases throughput capability …
GenScript Biotech - Wikipedia
In November 2023, Legend Biotech and Novartis signed an out-license deal to develop and manufacture Legend's chimeric antigen receptor (CAR-T) therapies, which target delta-like …